New anti-diabetic agents for the treatment of non-alcoholic fatty liver disease: a systematic review and network meta-analysis of randomized controlled trials.

Front Endocrinol (Lausanne) · 2023 · PMC10335801 · PMID 37441498

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

SGLT-2is and DPP-4is showed a trend for improved liver enzyme profiles for both direct and indirect comparisons compared to SoC alone, although this was not significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.